Cargando…
Predicting Outcome in dogs with Primary Immune‐Mediated Hemolytic Anemia: Results of a Multicenter Case Registry
BACKGROUND: Outcome prediction in dogs with immune‐mediated hemolytic anemia (IMHA) is challenging and few prognostic indicators have been consistently identified. OBJECTIVES: An online case registry was initiated to: prospectively survey canine IMHA presentation and management in the British Isles;...
Autores principales: | Goggs, R., Dennis, S.G., Di Bella, A., Humm, K.R., McLauchlan, G., Mooney, C., Ridyard, A., Tappin, S., Walker, D., Warman, S., Whitley, N.T., Brodbelt, D.C., Chan, D.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864895/ https://www.ncbi.nlm.nih.gov/pubmed/26473338 http://dx.doi.org/10.1111/jvim.13642 |
Ejemplares similares
-
The use of high‐dose immunoglobulin M‐enriched human immunoglobulin in dogs with immune‐mediated hemolytic anemia
por: Bestwick, Jason P., et al.
Publicado: (2021) -
Urinary 11‐dehydrothromboxane B(2)
concentrations in 20 dogs with primary immune‐mediated hemolytic anemia
por: Conway, Elizabeth A., et al.
Publicado: (2021) -
Cell‐Free DNA and DNase Activity in Dogs with Immune‐Mediated Hemolytic Anemia
por: Jeffery, U., et al.
Publicado: (2017) -
Carboxyhemoglobin as a diagnostic and prognostic biomarker of hemolytic anemias in dogs
por: Nivy, Ran, et al.
Publicado: (2022) -
Reactive oxygen species, glutathione, and vitamin E concentrations in dogs with hemolytic or nonhemolytic anemia
por: Woolcock, Andrew D., et al.
Publicado: (2020)